Showing results (451-460 of 561) with videos related to
Sort By:
Pageof 57
Ecology Letters|June 25, 2016
Impacts of warming and elevated CO2 on a semi-arid grassland are non-additive, shift with precipitation, and reverse over timeK E Mueller, D M Blumenthal, E Pendall, et al.FEBS Letters|March 30, 1992
Characterization of the RDC1 gene which encodes the canine homolog of a proposed human VIP receptor. Expression does not correlate with an increase in VIP binding sitesJ S Cook, D H Wolsing, J Lameh, et al.The Oncologist|March 28, 2019
FDA Approval Summary: Brentuximab Vedotin in First-Line Treatment of Peripheral T-Cell LymphomaNicholas C Richardson, Yvette L Kasamon, Haiyan Chen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Overall response rate, progression-free survival, and overall survival with targeted and standard therapies in advanced non-small-cell lung cancer: US Food and Drug Administration trial-level and patient-level analysesGideon M Blumenthal, Stella W Karuri, Hui Zhang, et al.The Journal of Biological Chemistry|July 6, 2023
Biochemical and structural characterization of the first-discovered metazoan DNA cytosine-N4 methyltransferase from the bdelloid rotifer Adineta vagaJujun Zhou, John R Horton, Gundeep Kaur, et al.Nucleic Acids Research|February 25, 1988
McrA and McrB restriction phenotypes of some E. coli strains and implications for gene cloningE A Raleigh, N E Murray, H Revel, et al.Archives of Toxicology|August 20, 2002
Pharmacokinetic profile and placental transfer of a single intravenous injection of [(14)C]chlorpyrifos in pregnant ratsAli A Abdel-Rahman, Gregory M Blumenthal, Sherif A Abou-Donia, et al.Journal of Experimental Botany|August 12, 2000
Decreased NADH glutamate synthase activity in nodules and flowers of alfalfa (Medicago sativa L.) transformed with an antisense glutamate synthase transgeneM A Schoenbeck, S J Temple, G B Trepp, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2019
Analysis of time-to-treatment discontinuation of targeted therapy, immunotherapy, and chemotherapy in clinical trials of patients with non-small-cell lung cancerG M Blumenthal, Y Gong, K Kehl, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapyC E McCoach, G M Blumenthal, L Zhang, et al.Pageof 57